ABC-话题@MedSci

#ABC#

108篇内容 | 2449人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1777032, encodeId=9f9d1e77032de, content=<a href='/topic/show?id=45ae1e1830' target=_blank style='color:#2F92EE;'>#ABC#</a>, objectTitle=SABCS 2014：低脂饮食可延长ER-乳腺癌患者生存, objectType=article, longId=44404, objectId=871944404b0, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=871944404b0, replyNumber=0, likeNumber=63, createdTime=2015-04-11, rootId=0, userName=cmj21wellington, userId=a54039078223, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=871944404b0, moduleTitle=SABCS 2014：低脂饮食可延长ER-乳腺癌患者生存, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=871944404b0)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1777034, encodeId=eeb11e77034fa, content=<a href='/topic/show?id=45ae1e1830' target=_blank style='color:#2F92EE;'>#ABC#</a>, objectTitle=SABCS 2014：乳腺癌放疗能否提高患者生存率, objectType=article, longId=44409, objectId=3a8c444091c, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=3a8c444091c, replyNumber=0, likeNumber=53, createdTime=2015-08-11, rootId=0, userName=cmj21wellington, userId=a54039078223, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=3a8c444091c, moduleTitle=SABCS 2014：乳腺癌放疗能否提高患者生存率, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=3a8c444091c)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1777030, encodeId=ac371e7703025, content=<a href='/topic/show?id=45ae1e1830' target=_blank style='color:#2F92EE;'>#ABC#</a>, objectTitle=SABCS 2014：默沙东PD-1免疫疗法Keytruda展现三阴乳腺癌（TNBC）治疗潜力, objectType=article, longId=43990, objectId=6f7c43990df, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=6f7c43990df, replyNumber=0, likeNumber=77, createdTime=2015-06-27, rootId=0, userName=cmj21wellington, userId=a54039078223, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=6f7c43990df, moduleTitle=SABCS 2014：默沙东PD-1免疫疗法Keytruda展现三阴乳腺癌（TNBC）治疗潜力, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=6f7c43990df)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1777038, encodeId=32671e770382a, content=<a href='/topic/show?id=45ae1e1830' target=_blank style='color:#2F92EE;'>#ABC#</a>, objectTitle=SABCS 2014：乳腺癌的个体化**放疗, objectType=article, longId=44430, objectId=f94d4443055, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f94d4443055, replyNumber=0, likeNumber=65, createdTime=2015-09-08, rootId=0, userName=cmj21wellington, userId=a54039078223, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f94d4443055, moduleTitle=SABCS 2014：乳腺癌的个体化**放疗, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=f94d4443055)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1777037, encodeId=3abe1e77037d4, content=<a href='/topic/show?id=45ae1e1830' target=_blank style='color:#2F92EE;'>#ABC#</a>, objectTitle=SABCS 2014：PD-1免疫疗法展现三阴乳腺癌治疗潜力, objectType=article, longId=44419, objectId=618d444197c, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=618d444197c, replyNumber=0, likeNumber=54, createdTime=2015-05-30, rootId=0, userName=cmj21wellington, userId=a54039078223, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=618d444197c, moduleTitle=SABCS 2014：PD-1免疫疗法展现三阴乳腺癌治疗潜力, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=618d444197c)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1777036, encodeId=f03d1e77036e6, content=<a href='/topic/show?id=45ae1e1830' target=_blank style='color:#2F92EE;'>#ABC#</a>, objectTitle=SABCS 2014：内分泌治疗耐药ER阳性乳腺癌研究, objectType=article, longId=44416, objectId=031e4441620, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=031e4441620, replyNumber=0, likeNumber=57, createdTime=2015-12-03, rootId=0, userName=cmj21wellington, userId=a54039078223, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=031e4441620, moduleTitle=SABCS 2014：内分泌治疗耐药ER阳性乳腺癌研究, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=031e4441620)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1777029, encodeId=db301e77029db, content=<a href='/topic/show?id=45ae1e1830' target=_blank style='color:#2F92EE;'>#ABC#</a>, objectTitle=Circulation：乳腺癌患者预防心血管事件的ABCDE五条建议, objectType=article, longId=43681, objectId=b8504368113, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=b8504368113, replyNumber=0, likeNumber=63, createdTime=2015-08-03, rootId=0, userName=cmj21wellington, userId=a54039078223, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=b8504368113, moduleTitle=Circulation：乳腺癌患者预防心血管事件的ABCDE五条建议, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=b8504368113)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1777035, encodeId=439f1e7703545, content=<a href='/topic/show?id=45ae1e1830' target=_blank style='color:#2F92EE;'>#ABC#</a>, objectTitle=SABCS 2014：PD-1抗体治疗进展期三阴乳腺癌研究, objectType=article, longId=44415, objectId=f30a4441598, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f30a4441598, replyNumber=0, likeNumber=76, createdTime=2015-04-29, rootId=0, userName=cmj21wellington, userId=a54039078223, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f30a4441598, moduleTitle=SABCS 2014：PD-1抗体治疗进展期三阴乳腺癌研究, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=f30a4441598)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1777031, encodeId=40eb1e7703123, content=<a href='/topic/show?id=45ae1e1830' target=_blank style='color:#2F92EE;'>#ABC#</a>, objectTitle=SABCS 2014：Pembrolizumab使部分三阴性乳腺癌患者产生持续应答, objectType=article, longId=44049, objectId=e5794404941, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e5794404941, replyNumber=0, likeNumber=70, createdTime=2015-06-24, rootId=0, userName=cmj21wellington, userId=a54039078223, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e5794404941, moduleTitle=SABCS 2014：Pembrolizumab使部分三阴性乳腺癌患者产生持续应答, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=e5794404941)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1777033, encodeId=061d1e7703382, content=<a href='/topic/show?id=45ae1e1830' target=_blank style='color:#2F92EE;'>#ABC#</a>, objectTitle=SABCS 2014：PI3K抑制剂用于ER阳性AI耐药的晚期乳腺癌, objectType=article, longId=44407, objectId=20064440e2c, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=20064440e2c, replyNumber=0, likeNumber=66, createdTime=2014-12-31, rootId=0, userName=cmj21wellington, userId=a54039078223, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=20064440e2c, moduleTitle=SABCS 2014：PI3K抑制剂用于ER阳性AI耐药的晚期乳腺癌, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=20064440e2c)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1777026, encodeId=41fb1e77026b7, content=<a href='/topic/show?id=45ae1e1830' target=_blank style='color:#2F92EE;'>#ABC#</a>, objectTitle=SABCS 2013：三阴性乳腺癌新辅助化疗获益, objectType=article, longId=28682, objectId=bebf28682da, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=bebf28682da, replyNumber=0, likeNumber=70, createdTime=2014-09-06, rootId=0, userName=cmj21wellington, userId=a54039078223, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=bebf28682da, moduleTitle=SABCS 2013：三阴性乳腺癌新辅助化疗获益, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=bebf28682da)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1777028, encodeId=80d81e77028b3, content=<a href='/topic/show?id=45ae1e1830' target=_blank style='color:#2F92EE;'>#ABC#</a>, objectTitle=SABCS 2013：亮点荟萃, objectType=article, longId=31252, objectId=cd233125266, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=cd233125266, replyNumber=0, likeNumber=49, createdTime=2014-11-02, rootId=0, userName=cmj21wellington, userId=a54039078223, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=cd233125266, moduleTitle=SABCS 2013：亮点荟萃, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=cd233125266)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1777024, encodeId=b4dc1e7702403, content=<a href='/topic/show?id=45ae1e1830' target=_blank style='color:#2F92EE;'>#ABC#</a>, objectTitle=SABCS 2013：转移性乳腺癌靶向治疗新方法, objectType=article, longId=28680, objectId=22062868050, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=22062868050, replyNumber=0, likeNumber=59, createdTime=2014-04-21, rootId=0, userName=cmj21wellington, userId=a54039078223, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=22062868050, moduleTitle=SABCS 2013：转移性乳腺癌靶向治疗新方法, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=22062868050)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1777023, encodeId=51da1e77023f4, content=<a href='/topic/show?id=45ae1e1830' target=_blank style='color:#2F92EE;'>#ABC#</a>, objectTitle=SABCS 2013:聚焦乳腺癌领域的热点与进展, objectType=article, longId=28679, objectId=9025286e99e, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=9025286e99e, replyNumber=0, likeNumber=70, createdTime=2014-07-06, rootId=0, userName=cmj21wellington, userId=a54039078223, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=9025286e99e, moduleTitle=SABCS 2013:聚焦乳腺癌领域的热点与进展, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=9025286e99e)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1777025, encodeId=b5c01e770255a, content=<a href='/topic/show?id=45ae1e1830' target=_blank style='color:#2F92EE;'>#ABC#</a>, objectTitle=SABCS 2013：聚焦乳腺癌辅助治疗进展, objectType=article, longId=28681, objectId=afd92868195, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=afd92868195, replyNumber=0, likeNumber=74, createdTime=2014-04-29, rootId=0, userName=cmj21wellington, userId=a54039078223, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=afd92868195, moduleTitle=SABCS 2013：聚焦乳腺癌辅助治疗进展, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=afd92868195)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1777027, encodeId=1e221e77027b3, content=<a href='/topic/show?id=45ae1e1830' target=_blank style='color:#2F92EE;'>#ABC#</a>, objectTitle=SABCS 2013：带来的5大临床实践改变, objectType=article, longId=29495, objectId=ce2629495b7, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=ce2629495b7, replyNumber=0, likeNumber=90, createdTime=2014-07-23, rootId=0, userName=cmj21wellington, userId=a54039078223, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=ce2629495b7, moduleTitle=SABCS 2013：带来的5大临床实践改变, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=ce2629495b7)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1777021, encodeId=67251e770211b, content=<a href='/topic/show?id=45ae1e1830' target=_blank style='color:#2F92EE;'>#ABC#</a>, objectTitle=中山大学肿瘤防治中心“克服ABC转运泵介导的肿瘤多药抗药性研究”获重要突破, objectType=article, longId=17998, objectId=524e1e99863, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=524e1e99863, replyNumber=0, likeNumber=56, createdTime=2014-01-13, rootId=0, userName=cmj21wellington, userId=a54039078223, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=524e1e99863, moduleTitle=中山大学肿瘤防治中心“克服ABC转运泵介导的肿瘤多药抗药性研究”获重要突破, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=524e1e99863)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1777014, encodeId=63621e770146d, content=<a href='/topic/show?id=45ae1e1830' target=_blank style='color:#2F92EE;'>#ABC#</a>, objectTitle=SABCS：乳腺癌贝伐单抗治疗走向终点？, objectType=article, longId=12838, objectId=7ee712838a8, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=7ee712838a8, replyNumber=0, likeNumber=61, createdTime=2013-09-28, rootId=0, userName=cmj21wellington, userId=a54039078223, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=7ee712838a8, moduleTitle=SABCS：乳腺癌贝伐单抗治疗走向终点？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=7ee712838a8)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1777015, encodeId=a9f41e77015ea, content=<a href='/topic/show?id=45ae1e1830' target=_blank style='color:#2F92EE;'>#ABC#</a>, objectTitle=SABCS：专家聚焦圣安东尼奥大会热点, objectType=article, longId=12839, objectId=b11f12839f7, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=b11f12839f7, replyNumber=0, likeNumber=49, createdTime=2013-04-09, rootId=0, userName=cmj21wellington, userId=a54039078223, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=b11f12839f7, moduleTitle=SABCS：专家聚焦圣安东尼奥大会热点, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=b11f12839f7)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1777022, encodeId=e5b41e7702246, content=<a href='/topic/show?id=45ae1e1830' target=_blank style='color:#2F92EE;'>#ABC#</a>, objectTitle=科学家绘制ABC转运蛋白的细胞“路线图”, objectType=article, longId=21695, objectId=24df2169563, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=24df2169563, replyNumber=0, likeNumber=54, createdTime=2014-07-05, rootId=0, userName=cmj21wellington, userId=a54039078223, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=24df2169563, moduleTitle=科学家绘制ABC转运蛋白的细胞“路线图”, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=24df2169563)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

ABC

2020-05-29

cmj21wellington (审核中...)

前往app查看评论内容

#ABC#

SABCS 2014：低脂饮食可延长ER-乳腺癌患者生存

2015-04-11

cmj21wellington (审核中...)

前往app查看评论内容

#ABC#

SABCS 2014：乳腺癌放疗能否提高患者生存率

2015-08-11

cmj21wellington (审核中...)

前往app查看评论内容

#ABC#

SABCS 2014：默沙东PD-1免疫疗法Keytruda展现三阴乳腺癌（TNBC）治疗潜力

2015-06-27

cmj21wellington (审核中...)

前往app查看评论内容

#ABC#

SABCS 2014：乳腺癌的个体化**放疗

2015-09-08

cmj21wellington (审核中...)

前往app查看评论内容

#ABC#

SABCS 2014：PD-1免疫疗法展现三阴乳腺癌治疗潜力

2015-05-30

cmj21wellington (审核中...)

前往app查看评论内容

#ABC#

SABCS 2014：内分泌治疗耐药ER阳性乳腺癌研究

2015-12-03

cmj21wellington (审核中...)

前往app查看评论内容

#ABC#

Circulation：乳腺癌患者预防心血管事件的ABCDE五条建议

2015-08-03

cmj21wellington (审核中...)

前往app查看评论内容

#ABC#

SABCS 2014：PD-1抗体治疗进展期三阴乳腺癌研究

2015-04-29

cmj21wellington (审核中...)

前往app查看评论内容

#ABC#

SABCS 2014：Pembrolizumab使部分三阴性乳腺癌患者产生持续应答

2015-06-24

cmj21wellington (审核中...)

前往app查看评论内容

#ABC#

SABCS 2014：PI3K抑制剂用于ER阳性AI耐药的晚期乳腺癌

2014-12-31

cmj21wellington (审核中...)

前往app查看评论内容

#ABC#

SABCS 2013：三阴性乳腺癌新辅助化疗获益

2014-09-06

cmj21wellington (审核中...)

前往app查看评论内容

#ABC#

SABCS 2013：亮点荟萃

2014-11-02

cmj21wellington (审核中...)

前往app查看评论内容

#ABC#

SABCS 2013：转移性乳腺癌靶向治疗新方法

2014-04-21

cmj21wellington (审核中...)

前往app查看评论内容

#ABC#

SABCS 2013:聚焦乳腺癌领域的热点与进展

2014-07-06

cmj21wellington (审核中...)

前往app查看评论内容

#ABC#

SABCS 2013：聚焦乳腺癌辅助治疗进展

2014-04-29

cmj21wellington (审核中...)

前往app查看评论内容

#ABC#

SABCS 2013：带来的5大临床实践改变

2014-07-23

cmj21wellington (审核中...)

前往app查看评论内容

#ABC#

中山大学肿瘤防治中心“克服ABC转运泵介导的肿瘤多药抗药性研究”获重要突破

2014-01-13

cmj21wellington (审核中...)

前往app查看评论内容

#ABC#

SABCS：乳腺癌贝伐单抗治疗走向终点？

2013-09-28

cmj21wellington (审核中...)

前往app查看评论内容

#ABC#

SABCS：专家聚焦圣安东尼奥大会热点

2013-04-09

cmj21wellington (审核中...)

前往app查看评论内容

#ABC#

科学家绘制ABC转运蛋白的细胞“路线图”

2014-07-05

科室
- - 订阅+
  - 更多科室
工具
服务